Viewing data from:

MAPROTILINE HYDROCHLORIDE

ANDA

MAPROTILINE HYDROCHLORIDE | A072285 | RISING PHARMA HOLDING INC

3 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF2 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

OLON SPAMAPROTILINE HYDROCHLORIDE

DMF 70961987

BALENCO ENTERPRISES INCInactiveMAPROTILINE HYDROCHLORIDE USP

DMF 67301986

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveMAPROTILINE HYDROCHLORIDE

DMF 70181987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 3, 1988

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 3, 1988

#003 — 75MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 3, 1988